NIH-funded research R01 grant

Understanding how the surrounding tissue affects breast cancer development

Official title: Stromal contributions to breast carcinogenesis

Funded at University of Florida · NIH-10880612 · Data updated 2026-11-12

This study is looking at how the supportive tissue around breast cells might play a part in the early development of breast cancer, especially in people with benign breast conditions or high breast density, to help us understand the risks better.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startJuly 3, 2023
Project endJune 30, 2028
Funding year2024
Award (this year)$657,613
NIH project number5R01CA277817-02
Project IDNIH-10880612 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include women with benign breast disease or those with high mammographic breast density.

Less likely to help

Patients without benign breast disease or low mammographic breast density may not benefit from this research.

What this research studies

This research investigates the role of the stroma, the supportive tissue surrounding breast cells, in the early stages of breast cancer development. By analyzing data and biopsy samples from large health studies, the research aims to uncover how changes in the stroma contribute to benign breast disease and high breast density, both of which are linked to increased breast cancer risk. An interdisciplinary team will employ advanced techniques to explore these relationships and identify potential molecular mechanisms involved in breast carcinogenesis.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for early detection and prevention of breast cancer.

How similar studies have gone: While the role of stroma in advanced breast cancer has been studied, this investigation into its early contributions to carcinogenesis is relatively novel.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Yaghjyan, Lusine — University of Florida
  • Study coordinator: Yaghjyan, Lusine

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.